These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


826 related items for PubMed ID: 9728450

  • 1. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma.
    Chaudhuri S, Hajra SK, Mukherjee A, Saha B, Mazumder B, Chattapadhya D, Saha K.
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450
    [Abstract] [Full Text] [Related]

  • 2. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK, Sharma P.
    Indian J Lepr; 2008 Jun; 80(3):247-55. PubMed ID: 19432355
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prospective immunological follow-up in household contacts of Mexican leprosy patients.
    Amezcua ME, Escobar-Gutiérrez A, Barba-Rubio J, Cázares JV, Mayén E, Chávez-Núñez M, Peña RC, Rodríguez R, Pastén S.
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):651-9. PubMed ID: 2280115
    [Abstract] [Full Text] [Related]

  • 6. Specific anti-M leprae PGL-I antibodies and Mitsuda reaction in the management of household contacts in New Caledonia.
    Desforges S, Bobin P, Brethes B, Huerre M, Moreau JP, Bach MA.
    Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):794-800. PubMed ID: 2681462
    [Abstract] [Full Text] [Related]

  • 7. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG.
    Convit J, Aranzazu N, Pinardi M, Ulrich M.
    Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR, Chiplunkar SV, Butlin R, Samson PD, Deo MG, Gangal SG.
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
    Bapat CV, Modak MS, DeSouza NG, Chulawalla RG.
    Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
    [Abstract] [Full Text] [Related]

  • 13. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
    Chaudhury S, Hazra SK, Saha B, Mazumder B, Biswas PC, Chattopadhya D, Saha K.
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
    [Abstract] [Full Text] [Related]

  • 14. Induction of lepromin positivity following immuno-chemotherapy with Mycobacterium w vaccine and multidrug therapy and its impact on bacteriological clearance in multibacillary leprosy: report on a hospital-based clinical trial with the candidate antileprosy vaccine.
    Sharma P, Kar HK, Misra RS, Mukherjee A, Kaur H, Mukherjee R, Rani R.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):259-69. PubMed ID: 10575405
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of Mitsuda reaction to nude mouse and armadillo lepromin preparations using nine-banded armadillos.
    Job CK, Truman RW.
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):18-22. PubMed ID: 10834065
    [Abstract] [Full Text] [Related]

  • 16. Study of HLA-DR expression on skin lesions of leprosy before and during multiple drug therapy.
    Abdel Latif AM, Essa EA.
    Int J Lepr Other Mycobact Dis; 2002 Jun; 70(2):104-10. PubMed ID: 12211894
    [Abstract] [Full Text] [Related]

  • 17. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR, Janson AM, Thole JE, Buhrer S, Bos C, Soebono H, de Vries RR.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [Abstract] [Full Text] [Related]

  • 18. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
    Torres P, Camarena JJ, Gomez JR, Nogueira JM, Gimeno V, Navarro JC, Olmos A.
    Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
    [Abstract] [Full Text] [Related]

  • 19. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ, Baskin GB, Xu K, Ratterree MS, Mack PA, Bohm RP, Meyers WM, Walsh GP.
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [Abstract] [Full Text] [Related]

  • 20. Serial Mitsuda tests for identification of reactional tuberculoid and reactional borderline leprosy forms.
    Lastoria LC, Opromolla DV, Fleury RN, Habermann F, Curi PR.
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):190-200. PubMed ID: 9728451
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 42.